Sarah Aitken
Sarah Aitken is a vascular surgeon at the University of Sydney, known for her expertise in the field of heart surgery. Recently, she was in the news for her comments on the innovative BiVACOR device, a titanium artificial heart that has shown promise as a temporary solution for patients with heart failure awaiting donor transplants. Aitken highlighted both the potential and the challenges of using such advanced medical technology, emphasizing the need for further research to understand its long-term functionality and implications.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Australia | 2 | 5.50 | 0.14% | +0% | 25,499,884 | 34,483 | $1,380,000 | 1,866$ |
| Totals | 2 | 25,499,884 | 34,483 | $1,380,000 | 1,866$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Associate Professor Sarah Aitken stated that this is still a big area of unprioritised research.
5
Australia:
Associate Professor Sarah Aitken is the deputy chair of the Royal Australasian College of Surgeons’ vascular board.
6
North Macedonia:
Sarah Aitken is a vascular surgeon at the University of Sydney who commented on the innovative nature of the device.
8